HIGHLIGHTS
- who: Hongmei Sun and collaborators from the (CSIC), Spain Sku00e5ne University Hospital, Sweden have published the research work: DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is u226510 ng/ml, in the Journal: (JOURNAL)
- what: Given the limitations of PSA, TRUS, and PI-PRADS v2, this study investigated the clinical utility of DCE-MRI and DWI parameters for differentiating between PCa and BPH. The results of this study demonstrate that DCE-MRI and DWI parameters can differentiate between benign and malignant prostate tumors when serum PSA is u226510 ng . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.